tiprankstipranks
Genor Biopharma Holdings Limited (HK:6998)
:6998
Hong Kong Market
6998
Genor Biopharma Holdings Limited
RESEARCH TOOLSreports
Want to see HK:6998 full AI Analyst Report?

Genor Biopharma Holdings Limited (6998) Income Statement

3 Followers

Genor Biopharma Holdings Limited Income Statement

Last quarter (Q4 2025), Genor Biopharma Holdings Limited's total revenue was ¥2.41B, an increase of Infinity% from the same quarter last year. In Q4, Genor Biopharma Holdings Limited's net income was ¥445.96M. See Genor Biopharma Holdings Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 2.42B¥ 206.23M¥ 0.00¥ 15.93M¥ 0.00
Gross Profit
¥ 1.34B¥ 204.89M¥ 0.00¥ 14.95M¥ 0.00
Operating Expenses
¥ 722.25M¥ 277.44M¥ 711.20M¥ 801.15M¥ 859.11M
Depreciation and Amortization
¥ 309.83M¥ 65.28M¥ 65.28M¥ 53.68M¥ 44.01M
EBITDA
¥ 929.10M¥ -5.15M¥ -551.01M¥ -675.89M¥ -840.19M
Operating Income
¥ 619.27M¥ -72.55M¥ -711.20M¥ -786.21M¥ -859.11M
Other Income/Expenses
¥ -135.85M¥ 37.42M¥ 33.70M¥ 50.30M¥ -7.20M
Pretax Income
¥ 483.42M¥ -35.13M¥ -677.50M¥ -732.42M¥ -866.31M
Net Income
¥ 388.93M¥ -51.28M¥ -674.36M¥ -730.40M¥ -865.37M
Per Share Metrics
Basic EPS
¥ 0.23¥ -0.10¥ -1.33¥ -1.45¥ -1.75
Diluted EPS
¥ 0.22¥ -0.10¥ -1.33¥ -1.45¥ -1.74
Weighted Average Shares Outstanding
 1.67B 513.55M 506.25M 504.30M 495.18M
Weighted Average Shares Outstanding (Diluted)
 1.70B 513.55M 506.25M 504.81M 496.20M
Currency in CNY

Genor Biopharma Holdings Limited Earnings and Revenue History